APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Not yet recruiting
Phase of Trial: Phase II
Latest Information Update: 02 Sep 2017
At a glance
- Drugs Fenretinide (Primary)
- Indications Cystic fibrosis
- Focus Adverse reactions; Therapeutic Use
- Acronyms APPLAUD
- Sponsors Laurent Pharmaceuticals
- 25 Aug 2017 Status changed from planning to not yet recruiting.
- 19 Apr 2017 According to a Laurent Pharmaceuticals media release, company plans to initiate this study later 2017.
- 19 Apr 2017 According to a Laurent Pharmaceuticals media release, the company received the IND approval from the US FDA and the Clinical Trial Application ("CTA") with Health Canada.